insights_auto
Why is CYTK down ४.४२%?
Dive Deeperchevron_right
CYTK:NASDAQ
Cytokinetics, Inc.
US$ ६२.७०
arrow_downward
-४.४२%(-२.९०) 1D
US$ ६२.७०
०.००% (०.००)
bedtimeAfter hours
Closed: अक्टोबर ५, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
US$ ६५.६०
High
US$ ६५.७६
Low
US$ ६२.१९
Mkt. cap
८.७२ अरब
Avg. vol.
२०.३० लाख
Volume
३२.३४ लाख
52-wk high
US$ ८८.३१
52-wk low
US$ ५४.३०
EPS
-US$ ७.२२
Beta
०.४१
Shares outstanding
१३.९० करोड
No. of employees
६७३
Open
US$ ६५.६०
High
US$ ६५.७६
Low
US$ ६२.१९
Mkt. cap
८.७२ अरब
Avg. vol.
२०.३० लाख
Volume
३२.३४ लाख
52-wk high
US$ ८८.३१
52-wk low
US$ ५४.३०
EPS
-US$ ७.२२
Beta
०.४१
Shares outstanding
१३.९० करोड
No. of employees
६७३
News stories
From web sources and news partners
AD HOC NEWS
·
२३ घण्टा पहिले
Cytokinetics stock heads into four October heart presentations
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees६७३
Founded१९९७
HeadquartersSouth San Francisco, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitecytokinetics.com